GlassScriptPhysician profile
Steven A Harrison
NPI 1598857864
$6,363.21
in general payments reported to CMS, 2019-2025
50 companies · $2,816 in 2025
The $2,816 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $202 · 2021: $495 · 2022: $563 · 2023: $753 · 2024: $896 · 2025: $2,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,155 · Travel and Lodging: $1,216 · Education: $93.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,154.69 |
| Travel and Lodging | $1,215.82 |
| Education | $93.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,215.82 | 2025 | N/A |
| Janssen Biotech, INC. | $650.16 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $385.82 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $384.38 | 2020-2025 | |
| Pfizer INC. | $292.90 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $292.05 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $282.95 | 2022-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $260.63 | 2019-2024 | Myrbetriq, Xtandi |
| Dendreon Pharmaceuticals LLC | $250.76 | 2019-2025 | Provenge |
| Coloplast Corp | $205.13 | 2019-2024 | Self-Cath, Speedicath, Porges Coloplast |
| Endo Pharmaceuticals INC. | $186.55 | 2019-2023 | Xiaflex, Aveed, Edex |
| Urogen Pharma, INC. | $163.86 | 2022-2025 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $129.84 | 2021-2022 | |
| Antares Pharma, INC. | $126.31 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Ferring Pharmaceuticals INC. | $101.79 | 2024-2025 | Adstiladrin |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $96.15 | 2019-2023 | |
| Progenics Pharmaceuticals, INC. | $93.42 | 2023-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $93.07 | 2022-2025 | |
| Boston Scientific Corporation | $78.27 | 2019-2023 | Spaceoar System |
| Laborie Medical Technologies Corp. | $77.08 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Myovant Sciences INC. | $71.25 | 2021-2022 | |
| Abbvie INC. | $66.24 | 2022-2025 | |
| Urovant Sciences INC | $63.24 | 2021-2022 | |
| Rochester Medical Corporation | $61.15 | 2019 | |
| Bioprotect Medical, INC. | $60.43 | 2025 | Bioprotect Balloon Implant System |
| Endo USA, INC. | $51.04 | 2024 | Xiaflex |
| Tolmar, INC. | $47.17 | 2024-2025 | Eligard |
| Telix Pharmaceuticals | $45.46 | 2025 | Illuccix |
| C. R. Bard, INC. & Subsidiaries | $44.31 | 2022 | |
| Baxter Healthcare | $42.78 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $35.77 | 2023-2024 | Bridion, Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $35.35 | 2024-2025 | Lynparza |
| Accord Healthcare, INC. | $35.14 | 2025 | |
| Acerus Pharmaceuticals Corporation | $33.31 | 2021 | |
| Abc Home Medical Supply, INC. | $31.51 | 2025 | |
| Clarus Therapeutics INC. | $29.16 | 2021 | |
| Allergan, INC. | $25.99 | 2019-2022 | |
| Karl Storz Endoscopy-America | $22.05 | 2025 | |
| Angiodynamics, INC. | $22.01 | 2025 | Nanoknife |
| Myriad Genetic Laboratories, INC. | $20.61 | 2023 | Myrisk |
| Immunitybio, INC. | $19.96 | 2025 | |
| Bluewind Medical | $19.31 | 2025 | |
| Ambu INC. | $19.22 | 2025 | |
| Genzyme Corporation | $18.57 | 2020 | |
| Olympus America INC. | $14.13 | 2022 | |
| Neotract INC. | $14.10 | 2019 | |
| Isoray, INC | $13.52 | 2022 | |
| Mission Pharmacal Company | $13.38 | 2021 | |
| Amgen INC. | $12.57 | 2019 | |
| Travere Therapeutics, INC. | $7.54 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.